Hyundai Bioscience Co. Ltd (048410) — Cash Flow Quality Index
Hyundai Bioscience Co. Ltd (048410) has a Cash Flow Quality Index of 5.09x as of June 2024. Operating cash flow of ₩8.02 Billion exceeds net income of ₩1.58 Billion, indicating high earnings quality where cash backs reported profits. Explore 048410 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hyundai Bioscience Co. Ltd Cash Flow Quality Index (2008–2019)
Historical Cash Flow Quality Index for Hyundai Bioscience Co. Ltd across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Hyundai Bioscience Co. Ltd to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Hyundai Bioscience Co. Ltd (2008–2019)
Year-by-year earnings quality comparison for Hyundai Bioscience Co. Ltd. For live market cap and the full company financial profile, see Hyundai Bioscience Co. Ltd (048410) market capitalisation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | 11.96x | ₩9.18 Billion | ₩767.22 Million | ▲ +525.8% |
| 2018 | 1.91x | ₩5.01 Billion | ₩2.62 Billion | ▲ +163.0% |
| 2017 | -3.03x | ₩-3.70 Billion | ₩1.22 Billion | ▼ -2570.3% |
| 2015 | 0.12x | ₩87.36 Million | ₩711.29 Million | ▼ -93.8% |
| 2008 | 1.97x | ₩10.37 Billion | ₩5.26 Billion | — |